Skip Over Navigation Links

Funding & Notices

Small Business Opportunities

Meeting participants sit at conference tableNCATS seeks to increase small business participation in federally supported research and development as well as private-sector commercialization of technology developed with federal support. The Center achieves this through the federal government’s Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. Read more about programs, eligibility and applicant information.

NCATS also is interested in the application of clinical technology, instruments, devices and related methodologies that may have broad application to clinical research. In particular, NCATS funds applications that enhance clinical research and patient care. Read more about SBIR and STTR Topics of Interest.

For more information about small business opportunities at NCATS:

Open Funding Opportunities

Small Business Innovation Research (SBIR)

  • PA-14-307: Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44)
  • RFA-HL-15-008: Bioreactors for Reparative Medicine (R43/R44)
  • PAR-14-088: Direct Phase II SBIR Grants to Support Biomedical Technology Development
  • NOT-OD-14-048: NIH Implements Option for Applicants to Switch between the SBIR/STTR Programs and the SBIR Direct to Phase II Pilot of the SBIR/STTR Reauthorization Act of 2011
  • PA-14-071: PHS 2014-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
  • PAR-13-345: Development of Appropriate Pediatric Formulations and Drug Delivery Systems SBIR (R43)
  • RFA-HL-14-011: Onsite Tools and Technologies for Heart, Lung, and Blood Clinical Research Point-of-Care SBIR (R43/R44)
  • RFA-HL-14-012: Small Market Awards: SBIR Phase IIB Competing Renewals for Heart, Lung, Blood and Sleep Technologies with Small Commercial Markets (R44)

Small Business Technology Transfer (STTR)

  • PA-14-308: Platform Delivery Technologies for Nucleic Acid Therapeutics (R41/R42)
  • RFA-HL-15-004: Bioreactors for Reparative Medicine (R41/R42)
  • NOT-OD-14-048: NIH Implements Option for Applicants to Switch between the SBIR/STTR Programs and the SBIR Direct to Phase II Pilot of the SBIR/STTR Reauthorization Act of 2011
  • PA-14-072: PHS 2014-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42])
  • RFA-HL-14-017: Onsite Tools and Technologies for Heart, Lung, and Blood Clinical Research Point-of-Care STTR (R41/R42)
  • PAR-13-346: Development of Appropriate Pediatric Formulations and Drug Delivery Systems STTR (R41)

Related Links

Contact

Lili Portilla, M.P.A.


NCATS SBIR/STTR Webinar

On Oct. 27, 2014, NCATS and BIO co-hosted a webinar about the Center’s SBIR and STTR funding opportunities. 

Download the webinar video.
Right click and save target/file

Download the transcript.


NIH Launches I-Corps

NCATS and three other NIH Institutes participate in I-Corps at NIH pilot program to speed up development and commercialization of new products and services generated by projects funded through NIH’s SBIR and STTR awards.